Lymphatic Education & Research Network

Learn more at https://lnkd.in/ehuGzhMH The Jane Petty Translational Science Catalyst Award supported by LE&RN, a new funding opportunity created to accelerate the path from discovery to patient impact in lymphatic diseases. Established in honor of Jane Petty’s commitment to advancing lymphatic research, this award supports innovative projects that hold clear potential to improve diagnosis, treatment, prevention, or care for people living with lymphatic diseases. Award Highlights 🔹 $60,000 in total funding over two years (no indirect costs) 🔹 Supports proof-of-concept, pilot data, and feasibility studies 🔹 Open to applicants worldwide Application Process & Timeline 🔹 Letter of Intent (LOI) deadline: October 27, 2025 🔹 Full proposal deadline: November 10, 2025 🔹 Notice of Award: January 2026 For inquiries about this award, contact Dr. Ajit Muley, LE&RN Science & Medical Director at amuley@lymphaticnetwork.org

Understanding the Costs of Lymphedema in Breast Cancer Care New study The Division of Breast Surgery at The Ohio State University, in collaboration with Dana-Farber Cancer Institute, is inviting participants in their study to better understand the financial impact of preventing and treating lymphedema in breast cancer. Who can participate Breast cancer patients, survivors, caregivers, and healthcare providers. What does it take to participate Participants will complete a series of brief online activities over six months, including identifying and categorizing costs related to lymphedema care, and rating their influence on treatment decisions. Some participants may also be invited to take part in a short audio-recorded interview. Compensation for participants Participants will receive up to $75 in VISA gift cards for study completion. This study involves minimal risk, and no personal health information will be collected. For more information about the study and enrollments visit: https://lnkd.in/d5NeXDw

Join us today at 11:00 am ET for the LE&RN online symposium https://lnkd.in/ey49jWPg 📚 About the Symposium This complimentary symposium will provide updates on surgical lymphedema therapies, advances in preoperative and postoperative care, and the inclusion of lymphedema therapies in the Austrian governmental insurance system. 🤝 Who Should Attend? This symposium is primarily intended for clinicians, researchers, and policymakers, but all members of the lymphatic community are welcome to participate. 🩺 About the Speaker Prof. Dr. Chieh -Han John Tzou, MBA is the Director of the Department of Plastic and Reconstructive Surgery at the Hospital of Divine Savior in Vienna, Austria. He also serves as Director of the Lymphedema and Facial Palsy Center at TZOU MEDICAL. In addition, Dr. Tzou is Medical Faculty at Sigmund Freud University. 🎥 Will there be a recording? Yes! Recordings are available and complimentary in the LE&RN Symposium Library at lymphaticnetwork.org and posted to social media a few days after the symposium.

Learn more at https://lnkd.in/ehuGzhMH The Jane Petty Translational Science Catalyst Award supported by LE&RN, a new funding opportunity created to accelerate the path from discovery to patient impact in lymphatic diseases. Established in honor of Jane Petty’s commitment to advancing lymphatic research, this award supports innovative projects that hold clear potential to improve diagnosis, treatment, prevention, or care for people living with lymphatic diseases. Award Highlights 🔹 $60,000 in total funding over two years (no indirect costs) 🔹 Supports proof-of-concept, pilot data, and feasibility studies 🔹 Open to applicants worldwide Application Process & Timeline 🔹 Letter of Intent (LOI) deadline: October 27, 2025 🔹 Full proposal deadline: November 10, 2025 🔹 Notice of Award: January 2026 For inquiries about this award, contact Dr. Ajit Muley, LE&RN Science & Medical Director at amuley@lymphaticnetwork.org

We're #hiring a new Director of Communications in United States. Apply today or share this post with your network.

Register for our next free symposium on September 15 at 11:00 am ET at https://lnkd.in/ey49jWPg 📚 About the Symposium This complimentary symposium will provide updates on surgical lymphedema therapies, advances in preoperative and postoperative care, and the inclusion of lymphedema therapies in the Austrian governmental insurance system. 🤝 Who Should Attend? This symposium is primarily intended for clinicians, researchers, and policymakers, but all members of the lymphatic community are welcome to participate. 🩺 About the Speaker Prof. Dr. Chian-Han John Tzou is the Director of the Department of Plastic and Reconstructive Surgery at the Hospital of Divine Savior in Vienna, Austria. He also serves as Director of the Lymphedema and Facial Palsy Center at TZOU MEDICAL. In addition, Dr. Tzou is Medical Faculty at Sigmund Freud University. 🎥 Will there be a recording? Yes! Recordings are available and complimentary in the LE&RN Symposium Library at lymphaticnetwork.org and posted to social media a few days after the symposium.

Learn more at https://lnkd.in/ehuGzhMH LE&RN is pleased to announce the Jane Petty Translational Science Catalyst Award, a new funding opportunity created to accelerate the path from discovery to patient impact in lymphatic diseases. Established in honor of Jane Petty’s commitment to advancing lymphatic research, this award supports innovative projects that hold clear potential to improve diagnosis, treatment, prevention, or care for people living with lymphatic diseases. Award Highlights 🔹 $60,000 in total funding over two years (no indirect costs) 🔹 Supports proof-of-concept, pilot data, and feasibility studies 🔹 Open to applicants worldwide Application Process & Timeline 🔹 Letter of Intent (LOI) deadline: October 27, 2025 🔹 Full proposal deadline: November 10, 2025 🔹 Notice of Award: January 2026 For inquiries about this award, contact Dr. Ajit Muley, LE&RN Science & Medical Director, at amuley@lymphaticnetwork.org

▶️ Watch the free recording now: https://lnkd.in/e7Rgiau 💡 Bringing to Light the Invisible This symposium explored how a deeper understanding of functional lymphatic anatomy may inform how we can prevent #lymphedema in cancer patients and develop solutions for people living with lymphedema. 🔹 About the Speaker Dhruv Singhal, MD, is a pioneer in immediate lymphatic reconstruction for the prevention of lymphedema in high-risk patients and performs liposuction, lymphovenous bypass, and lymph node transplantation for the treatment of chronic lymphedema. Dr. Singhal serves as the Co-Director of the Boston Lymphatic Center and Director of the Beth Israel Deaconess Medical Center (BIDMC) Lymphatic Center, a LE&RN Comprehensive Center of Excellence.

📖 Read the full article exposing systemic failure to prioritize lymphatics and heartfelt perspectives from people living with lymphatic diseases: https://lnkd.in/ePHFmeh7 Despite affecting millions, lymphedema remains one of the least understood diseases and is now facing devastating federal research cuts. Deseret News investigates why, spotlighting voices from the LE&RN community: Huntsman Cancer Institute, LE&RN Center of Excellence Col. Susan F., LE&RN Ambassador William Repicci, LE&RN President & CEO

🚨 Take action here: https://lnkd.in/eJcZ-kwR Every year, we must fight to make sure lymphatic diseases are included in the Department of Defense’s Peer-Reviewed Medical Research Program (PRMRP). Right now, they are NOT on the list for FY 2025. Why This Matters ✅ In 2023, advocates like you made history—PRMRP funded lymphatic disease research for the first time. ✅ $7M awarded in 2023, $5M in 2024 = $12M total investment toward treatments and cures. ✅ PRMRP funding is open to researchers worldwide—impacting the entire global lymphatic community, not just the U.S. ⏳ Deadline: September 26 We must act NOW to ensure lymphatic diseases are included again this year. ✨ This is our first Advocacy Action Alert on the new Congress Plus platform—making advocacy easier than ever.